A study of factors affecting the labelling of tartrate with 188Re and the transchelation of the 188Re from the tartrate to a protein

Applied Radiation and Isotopes

Volumn 59, Issue 5-6, 2003, Pages 311-319

  Sailerova, Eva ^a   Billinghurst, Mervyn W ^a  

^a HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Ascorbate; Perrhenate; Radiolysis; Rhenium 188; Tartrate; Transchelation

Indexed keywords

OXIDATION; PH; PROTEINS; RADIOACTIVITY;

TRANSCHELATION;

CHELATION;

ALBUMIN; ASCORBIC ACID; FERROUS SULFATE; OXYGEN; RHENIUM 188; TARTARIC ACID RE 188; UNCLASSIFIED DRUG;

AIR; ARTICLE; CHELATION; COMPLEX FORMATION; EXPOSURE; HUMAN; ISOTOPE LABELING; OXIDATION; PH; PRIORITY JOURNAL;

EID: 0242402041     PISSN: 09698043     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apradiso.2003.09.004     Document Type: Article

References (16)

1. Bayly, R.J., Evans, E.A., 1966. J. Label Compounds 2, 1-34.
2. Chakrabarti M.C., Le N., Paik C.H., De Graff W.G., Carrasquillo J.A. Prevention of radiolysis of monoclonal antibody during labeling. J. Nucl. Med. 37:1996;1384-1388.
3. 99mTc-labeled radiopharmaceuticals Semin. Nucl. Med. 20:1990;5-27.
4. Duke F.R., Peterson N.C. The Tin (II) reduction of methyl orange. J. Phys. Chem. 63:1959;2076-2077.
5. Griffiths G.L., Knapp F.F. Jr., Callahan A.P., Chang C.H., Hansen H.J., Goldenberg D.M. Direct radiolabeling of monoclonal antibodies with generator produced rhenium-188 for radioimmunotherapy. Can. Res. 51:1991;4594.
6. 188Re. initial results with stannous ion reduction J. Nucl. Biol. Med. 38:1994;445.
7. Knapp F.F. Jr., Beets A.L., Guhlke S., Zamora P.O., Bender H., Palmedo H., Biersack H-J. Development of the alumina based tungsten-18888/rhenium-188 generator and the use of rhenium-188 labeled radiopharmaceuticals for cancer treatment. Anticancer Res. 17:1997;1783-1796.
8. Lin W-Y., Lin C-P., Yeh S-J., Hsieh B-T., Tsai Z-T., Ting G., Yen T-C., Wang S-J., Knapp F.F., Stabin M.G. Rhenium-188 hydroxyethylidene diphosphomate. a new generator produced therapeutic drug of potential value for the treatment of bone metastases Euro. J. Nucl. Med. 24:1997;590-595.
9. 99mTc labelled serum albumin for scintillation scanning of the placenta. J. Nucl. Med. 5:1964;936-946.
10. 99mTc generator technology. Int. J. Appl. Radiat. Isot. 33:1982;811-819.
11. 188Re labelled compounds. Int. J. Appl. Radiat. Isot. 58:2003;353-359.
12. Steigman, J., Eckelman, W.C., 1992. The chemistry of Technetium in Medicine Nuclear Science Series. National Academy Press, NAS-NS-3204, pp. 106-109.
13. Stern, H.S., McAfee, J.G., Zolle, I., 1966. Technetium-99-m-albumin. AEC Symp. Series 6, 352-382.
14. Sykes T.R., Somayaji V., Bier S., Woo T.K., Kwok C.S., Sniecklus V., Noujaim A. Radiolabeling of monoclonal antibody B43.13 with rhenium-188 for immunoreactivity. Int. J. Appl. Radiat. Isot. 48:1997;899-906.
15. Vanysek, P., 1986. Electrochemical Series pp D-152. In: Weast, R.C. (Ed.), CRC Handbook of Chemistry and Physics, CRC Press.
16. Winnard P. Jr., Virzi M., Fogarasi M., Rusckowski M., Hnatowich D.J. Investigations of directly labeling antibodies with rhenium-188. Q. J. Nucl. Med. 40:1996;151-160.